Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Anaheim. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Anaheim at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
This is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with schizophrenia with an inadequate response to their current antipsychotic treatment who previously completed the treatment period (Visit 8/Day 42 ± 3) of ARISE Study (KAR-012). The primary objective of the study is to assess the long-term safety and tolerability of adjunctive KarXT (a fixed dose combination of xanomeline and t
Sponsor: Karuna Therapeutics
Check if you qualify for this schizophrenia clinical trial in Anaheim, CA
If you're searching for schizophrenia treatment options in Anaheim, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anaheim research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.